kim solez renal transplant pathology and future perspectives
TRANSCRIPT
![Page 1: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/1.jpg)
Renal Transplant Pathology (The Rest of the Story Beyond Rejection) and Future Perspectives
Kim Solez, MD
![Page 2: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/2.jpg)
Michael Mengel gave a TTS webinar on rejection on October 20th 2015. In this presentation I will talk about the remaining issues in transplant pathology, general approaches, and the future.
![Page 3: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/3.jpg)
The Importance of Rooms and Places in the Generation of Important Ideas and Actions.
Pathology Library, Johns Hopkins Hospital
![Page 4: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/4.jpg)
Importance of Rooms and Places (Paris!) in Generation of Important Ideas and Actions.
![Page 5: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/5.jpg)
Objectives of this Presentation One hundred and thirty year history of
transplant pathology, 100 years back, 30 years forward.
To present a general approach to transplant pathology, special stains, and adjunctive procedures.
To introduce you to the concept of tissue engineering pathology and show its evolution from and relation to transplant pathology.
To present transplant pathology and tissue engineering pathology in an accessible way so people who do not regularly think about anatomical pathology like aviator Charles Lindberg (1902-1974) could understand it.
To introduce you to prototypical people from the future your offspring may resemble someday (in 2045)!
![Page 6: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/6.jpg)
Alexis Carrel/Charles Lindberg
In February 2002, theMedical University of South Carolina at Charleston in celebration of Lindberg’s 100th birthday established the Lindberg-Carrel Prize, given to major contributors to “development of perfusion and bio reactor technologies for organ preservation and growth”. M. E. DeBakey and nine other scientists received the prize, a bronze statuette expressly created for the event by the Italian artist C. Zoli and named “Elisabeth”, after Elisabeth Morrow, who died as a result of heart disease. Lindberg was disappointed that contemporary medical technology could not provide an artificial heart pump that would allow for for heart surgery on Elisabeth and that led to the first contact between Carrel and Lindberg.
![Page 7: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/7.jpg)
Alexis Carrel
In 1902, Alexis Carrel started the modern field of transplantation by describing surgical vascular anastomoses for transplantation, work that eventually resulted in his receiving the Nobel Prize. The first transplant pathology paper was published 13 years later: Hesselberg C: A comparison of autoplastic and homeoplastic transplantation of thyroid tissue in the guinea pig, J. Exp. Med. 1915 Feb 1:21(2):164-178.2015 is the centennial of this first publication in transplantation pathology
![Page 8: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/8.jpg)
Robert Heptinstall/Ken PorterMy mentor was Robert Heptinstall. In the early editions of his iconic textbook Kendrick Porter wrote the chapters on transplantation pathology. Porter collaborated for more than thirty years with transplant pioneer Thomas Starzl.
![Page 9: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/9.jpg)
24 years ago Kim Solez and Lorraine Racusen Directed the First Banff Meeting Which Created the Banff Classification of Transplant Pathology
![Page 10: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/10.jpg)
BANFF CLASSIFICATION STANDARD FOR TRANSPLANT BIOPSY INTERPRETATIONBegan in kidney (Solez et al. 1993), and was then
extended to liver, pancreas, composite tissue grafts etc. Meetings also consider heart, lung, small bowel.
Uses semiquantitative lesion scoring 0-3+ and diagnostic categories. A pathologic classification of all pathologic changes, not just rejection.
![Page 11: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/11.jpg)
Polys in peritubular capillaries in antibody-mediated rejection.
![Page 12: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/12.jpg)
![Page 13: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/13.jpg)
![Page 14: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/14.jpg)
The Banff Classification Deals with All Pathologic Conditions, Not Just Rejection. For Genomic Approaches to Take Off They Also Need to Deal with All Conditions, Be Affordable, and Capable of Being Standardized.
At present the Banff Classification uses mainly techniques from 30-60 years ago. More modern approaches would be welcomed!(Experts in pathology can skip next 12 slides, next 12 minutes.)
Affymetrix GeneChip® probe array. Image courtesy of Affymetrix.
![Page 15: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/15.jpg)
Diseases Which Commonly Recur Following Transplantation
FSGSMembranous GlomerulopathyIgA NephropathyMPGN IMPGN II (Dense Deposit Disease, C3 Glomerulopathy)SLE
![Page 16: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/16.jpg)
Diseases Which Commonly Appear De Novo Following Transplantation
Diabetic Nephropathy Anti-GBM Nephritis in Alport SyndromeIgA NephropathyMembranous NephropathyFSGSPost-Infectious GN
![Page 17: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/17.jpg)
Transplanted Kidney is Still A Kidney, Can Be Affected By Any of the Diseases that Affect Native Kidneys Such As Post-Infectious Glomerulonephritis
![Page 18: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/18.jpg)
Transplanted Kidney is Still A Kidney, All Four Compartments Should Be Described, With Number of Glomeruli and Vessels.
TubulesInterstitiumGlomeruliVessels
Light microscopy, electron microscopy, and immunofluorescence are standard.
![Page 19: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/19.jpg)
![Page 20: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/20.jpg)
Transplanted Kidney is Still A Kidney, Standard Special Stains Should Be Employed.
H&E, PAS,Silver Stain, Trichrome.Martius Scarletfor Fibrin.
Membranous GNThis case shows “spikes” on silver stain.
![Page 21: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/21.jpg)
![Page 22: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/22.jpg)
![Page 23: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/23.jpg)
![Page 24: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/24.jpg)
![Page 25: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/25.jpg)
![Page 26: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/26.jpg)
![Page 27: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/27.jpg)
BV Virus Nephropathy, Nuclear Inclusions, SV40 stain. http://ndt.oxfordjournals.org/content/15/3/324/F1.expansion
![Page 28: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/28.jpg)
![Page 29: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/29.jpg)
The Influences Shaping This Presentation
Kim Solez, Korey C. Fung, Khouloud Saliba, Victoria Sheldon, James F. Burdick, William H. Fissell, Anthony J. Demetris, and Lynn D. Cornell - Authors of the tissue engineering pathology manuscript in preparation.
Jason Wertheim, Harald Ott, and Shuvo Roy, regenerative medicine experts who teach in my Technology and Future of Medicine course LABMP 590 http://www.singularitycourse.com
![Page 30: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/30.jpg)
Stem Cell Technologies on Google Trends – News Headlines and Forecast
![Page 31: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/31.jpg)
Current transplant protocols reach fewer than 10% of those in need.
![Page 32: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/32.jpg)
Worldwide 1.2 million people are in need of transplantation for end stage organ failure. Current transplant protocols reach fewer than 10% of this number. Regenerative medicine can save the remaining 90%, over one million people annuallly!
![Page 33: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/33.jpg)
ViaCyte Announces Highly Anticipated Encapsulation Clinical
Trial Site Expansion into Canada JDRF-funded researcher, Dr. James Shapiro
will be the lead investigator at the Canadian site. TORONTO, July 29, 2015 -- ViaCyte, Inc. announced the opening of a second site in its Phase 1/2 trial for Type I Diabetes which utilizes PEC-01™ pancreatic progenitor cells and the proprietary Encaptra® drug delivery system which is designed to protect the transplanted cells from a patient’s immune system.
Regenerative Medicine Already Here! Viacyte Trial for Diabetes Therapy.
![Page 34: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/34.jpg)
Double Think: Stem Cells are Greatest Hope and Greatest Hype, Stem Cell Tourism Estimated to be $3 Billion a Year Industry and Growing, with More than 700 Clinics Worldwide
Mason C et al. Regen Med. 2011 May;6(3):265-72. doi: 10.2217/rme.11.28. Cell therapy industry: billion dollar global business with unlimited potential.
Timothy Caulfield - Stem Cell Tourism June 2015https://www.youtube.com/watch?v=B0r89nMtg10
![Page 35: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/35.jpg)
Channel the Energy of the Regret Felt About Stem Cell Hype, Stem Cell Tourism, and Stem Cell Fraud into Support for the Enormous Benefit for Humanity that Can Come from Well-Conducted Stem Cell Research.
My Avoca Central School high school graduation speech “Youth Rebellion” many years ago talked about sublimation, rechanneling the raw energy of primitive instincts into productive pursuits. The same concept applies here. Channel the emotional energy we feel about stem cells into support of high quality stem cell research.
![Page 36: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/36.jpg)
The Positive Aspects of Stem Cell Therapies,The True Hope, Has Potential to Reverse Three Looming Problems in Medicine:
1. The loss of “luster” in transplantation.2. Workforce problems in nephrology due to lack of appeal to young people/potential trainees worldwide.
3. Technological unemployment in medicine due to replacement of human workers by machines.
![Page 37: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/37.jpg)
Nephrologists & Renal Pathologists May Be Only People Still Employed in 2045!
![Page 38: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/38.jpg)
Sina Marzoughi Found An Image Showing What 2045 Will Look Like
![Page 39: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/39.jpg)
What Human Beings Will Look Like in 2045!
![Page 40: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/40.jpg)
Banff Classification of Kidney Transplant Pathology
Histologic criteria for the diagnosis of rejection and other conditions in the transplanted kidney, began 1991, updated and expanded every two years in consensus meeting.
![Page 41: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/41.jpg)
Significance of ‘Banff papers’• More than 5,000 citations of the 14 Banff meeting reports• 915 Banff / Transplantation papers in PubMed• Banff 2003 meeting report (ABMR criteria) = most cited AJT
paper• 3 Banff meeting reports are among the top 4 cited AJT articles
![Page 42: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/42.jpg)
Tissue Engineering Pathology Added Soon!•
![Page 43: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/43.jpg)
The World is Changing Rapidly!
![Page 44: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/44.jpg)
The World is Changing Rapidly!
![Page 45: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/45.jpg)
The World is Changing Rapidly!
![Page 46: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/46.jpg)
The World is Changing Rapidly!
![Page 47: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/47.jpg)
Canadian Data on Public Interest in Regenerative Medicine
![Page 48: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/48.jpg)
The Technological Singularity
![Page 49: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/49.jpg)
Podocytes go wandering into the interstitium! Song et al.
![Page 50: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/50.jpg)
Many problems with stem cell generate organs not being discussed. Do not exclude yourself from the conversation in this area!
![Page 51: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/51.jpg)
Many problems with stem cell generate organs not being discussed. Need to get those conversations to happen.
The recellularized organ clots like crazy, impossible to regenerate more than 80% of endothelial surface. Artificial heparinized surface not fenestrated. Cell traffic abnormal.
Hard to get right types of cells to right places. Podocytes seems to be terminally differentiated cells,
when attempt to culture them they turn into different type of cell.
Kidney progenitor stem cell difficult to identify, kidney work has lagged behind.
Easy to make stem cell generated kidneys that lack loop of Henle. Could produce lethal polyuria. What is “function”?
Many old fashioned questions of physiology about how the stem cell generated organ works, not just true for kidney, true for every organ. Logo still works for future!
![Page 52: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/52.jpg)
Banff Foundation for Allograft Pathology and Banff Meetings Must Adapt to Future Changes in Field of Transplantation
Transplant pathologists will also become tissue engineering pathologists, pathologists who analyze organs grown from stem cells. This is not something beyond us, we can adapt to a work life that includes stem cells. Someone needs to cross the disciplines.
![Page 53: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/53.jpg)
It is OK to Allow the Natural Resistance to Change and Nostalgia for the Past to Motivate You!
Many of the questions that need to be posed about stem cell generated organs are old fashioned questions, intact nephron hypothesis, cell regeneration, stunned myocardium, contraction band necrosis etc. Use your nostalgia! Stimulate conversations between stem cell researchers and transplant physicians.
![Page 54: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/54.jpg)
Beginning at the Very Beginning! “We are at the very beginning of time for the
human race. It is not unreasonable that we grapple with problems. But there are tens of thousands of years in the future. Our responsibility is to do what we can, learn what we can, improve the solutions, and pass them on.” - Richard P. Feynman, (1918-1988) Physicist, Nobel Prize Winner
"The sense of the future is behind all good policies. Unless we have it, we can give nothing either wise or decent to the world." - Snow CP, (1905-1980) Novelist and Philosopher.
"To a large extent, the future lies before us like a vast wilderness of unexplored reality. The God who created and sustained the evolving universe through eons of progress and development has not placed our generation at the tag end of the creative process. God has placed us at a new beginning. We are here for the future." - Sir John Templeton (1912-2008 ), Financial Analyst
![Page 55: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/55.jpg)
Beginning at the Very Beginning!
Like 1851 when the first International Classification of Diseases was presented in the Grand Exhibition of Technology at London’s Crystal Palace
Emphasis was on cause of death
![Page 56: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/56.jpg)
Classification focus is on sustaining life. Native and transplanted organ diseases can also
occur in tissue engineered organs. Includes ex vivo repair.
The classification focus of the new pathology discipline of Regenerative Medicine/Tissue Engineering Pathology is exactly the opposite of traditional classification of disease which starts with causes of death. In Regenerative Medicine/Tissue Engineering Pathology the emphasis is on the degree of normality necessary to sustain life:
Normal, Abnormalities of unknown functional significance, Abnormalities which will impair the main functions
of the organ, Abnormalities leading to severe organ dysfunction
where function may not be great enough to sustain life.
![Page 57: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/57.jpg)
Song et al. Interstitium, vessels, and glomeruli with missing cells. Disordered tubule formation with multiple interconnecting lumina of differing sizes. “Can you really call this a kidney?” (Yes!)
![Page 58: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/58.jpg)
Song et al. In addition to missing cells and disordered structures,you have cells in the wrong places. Podocytes in the interstitium.
![Page 59: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/59.jpg)
Focus of Tissue Engineering Pathology The specific questions become: 1. Are too many
cells missing, 2. Are too many cells in in the wrong places? 3. Are too many structures missing (long loops of Henle)? 4. Is there too much endothelial disruption for the organ to be properly perfused? 5. What are the risks of neoplastic transformation?
Classification categories should be not one-off, but reproducible, generalizable.
Tissue engineering pathology has been up to now really dull (articles since 1967), since most reports were of scaffolds with no inflammatory reaction "Move along, nothing to see here" pathology, but from today becomes really exciting with novel morphological changes and lives hanging in the balance, clinical trials starting!
Banff Classification of Tissue Engineering Pathology major focus 2017 meeting in Spain and 2019 in Turkey.
![Page 60: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/60.jpg)
In our original location we had mule deer poking their heads into the meeting rooms! We’ve come a
long way! Please help us transition to the future!
![Page 61: Kim Solez Renal transplant pathology and future perspectives](https://reader036.vdocuments.us/reader036/viewer/2022062522/589dd7011a28ab77148b476d/html5/thumbnails/61.jpg)
We are grateful to the Roche Organ Transplantation Research
Foundation for funding the establishment of the Banff
Foundation for Allograft Pathology from 2013-2016, our
infrastructure.